📈 Markets & Finance
Live
PolyPid's NDA For D-PLEX100 Receives FDA Priority Review, Stock Up
(RTTNews) - PolyPid Ltd. (PYPD) said on Wednesday that the U.S. Food and Drug Administration has accepted its New Drug Application for D-PLEX100 and granted the treatment Priority Review for the preve
Nasdaq News — 29 July 2026
Text:
28
0
0
(RTTNews) - PolyPid Ltd. (PYPD) said on Wednesday that the U.S. Food and Drug Administration has accepted its New Drug Application for D-PLEX100 and g
Read Full Story at Nasdaq News → Sources
📈 Markets & Finance
Trump finalizes new tariffs on dozens of countries
📈 Markets & Finance
Little Movement Seen For Thai Stock Market
📈 Markets & Finance
Ethereum Foundation adds SEAL 911 co-founder to board as privacy focus grows
📈 Markets & Finance
Higher Open Called For Indonesia Stock Market
📈 Markets & Finance
Analysts predict Chinese stock market rebound following U.S. election results
📈 Markets & Finance
American Airlines Cut Its Full-Year Guidance. The Stock Rose 6.8% the Next Day.
